Tuesday 25 October 2011

Amikacina Teva




Amikacina Teva may be available in the countries listed below.


Ingredient matches for Amikacina Teva



Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amikacina Teva in the following countries:


  • Italy

International Drug Name Search

Friday 21 October 2011

Gyno miconazolnitraat PCH




Gyno miconazolnitraat PCH may be available in the countries listed below.


Ingredient matches for Gyno miconazolnitraat PCH



Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Gyno miconazolnitraat PCH in the following countries:


  • Netherlands

International Drug Name Search

Thursday 20 October 2011

Oxistat




In the US, Oxistat (oxiconazole topical) is a member of the drug class topical antifungals and is used to treat Tinea Corporis, Tinea Cruris, Tinea Pedis and Tinea Versicolor.

US matches:

  • Oxistat Cream

  • Oxistat Lotion

  • Oxistat

  • Oxistat Topical

Ingredient matches for Oxistat



Oxiconazole

Oxiconazole is reported as an ingredient of Oxistat in the following countries:


  • United States

Oxiconazole nitrate (a derivative of Oxiconazole) is reported as an ingredient of Oxistat in the following countries:


  • Mexico

  • United States

International Drug Name Search

Wednesday 19 October 2011

Targretin


Targretin is a brand name of bexarotene, approved by the FDA in the following formulation(s):


TARGRETIN (bexarotene - capsule; oral)



  • Manufacturer: EISAI INC

    Approval date: December 29, 1999

    Strength(s): 75MG [RLD]

Has a generic version of Targretin been approved?


No. There is currently no therapeutically equivalent version of Targretin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Targretin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
    Patent 5,780,676
    Issued: July 14, 1998
    Inventor(s): Boehm; Marcus F. & Heyman; Richard A. & Zhi; Lin & Hwang; Chan Kou & White; Steve & Nadzan; Alex
    Assignee(s): Ligand Pharmaceuticals Incorporated
    Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and poiyenoic acid derivatives including carbocyclic polyenoic acids. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
    Patent expiration dates:

    • July 14, 2015
      ✓ 
      Patent use: TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY




  • Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
    Patent 5,962,731
    Issued: October 5, 1999
    Inventor(s): Boehm; Marcus F. & Heyman; Richard A.
    Assignee(s): Ligand Pharmaceuticals Incorporated
    Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
    Patent expiration dates:

    • October 5, 2016
      ✓ 
      Patent use: TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY




  • Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
    Patent 6,043,279
    Issued: March 28, 2000
    Inventor(s): Boehm; Marcus F. & Heyman; Richard A.
    Assignee(s): Ligand Pharmaceuticals, Incorporated
    Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
    Patent expiration dates:

    • April 22, 2012
      ✓ 
      Patent use: TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY




  • Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
    Patent 6,320,074
    Issued: November 20, 2001
    Inventor(s): Boehm; Marcus F. & Heyman; Richard A. & Zhi; Lin & Koch; Stacie Canan
    Assignee(s): Ligand Pharmaceuticals Incorporated
    Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
    Patent expiration dates:

    • April 22, 2012
      ✓ 
      Patent use: TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY
      ✓ 
      Drug substance




  • Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
    Patent 7,655,699
    Issued: February 2, 2010
    Inventor(s): Boehm; Marcus F. & Heyman; Richard A.
    Assignee(s): Eisai Inc.
    Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and polyenoic acid derivatives including carbocyclic polyenoic acids. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
    Patent expiration dates:

    • April 22, 2012
      ✓ 
      Patent use: TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Targretin Consumer Information (Wolters Kluwer)
  • Targretin Consumer Information (Cerner Multum)
  • Targretin Advanced Consumer Information (Micromedex)
  • Targretin AHFS DI Monographs (ASHP)
  • Bexarotene Consumer Information (Wolters Kluwer)
  • Bexarotene Consumer Information (Cerner Multum)
  • Bexarotene Advanced Consumer Information (Micromedex)
  • Bexarotene AHFS DI Monographs (ASHP)

Thursday 13 October 2011

Apex Enrofloxacin




Apex Enrofloxacin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Apex Enrofloxacin



Enrofloxacin

Enrofloxacin is reported as an ingredient of Apex Enrofloxacin in the following countries:


  • Australia

International Drug Name Search

Tuesday 11 October 2011

Morfina Cloridrato + Atropina Solfato Monico




Morfina Cloridrato + Atropina Solfato Monico may be available in the countries listed below.


Ingredient matches for Morfina Cloridrato + Atropina Solfato Monico



Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Morfina Cloridrato + Atropina Solfato Monico in the following countries:


  • Italy

Morphine

Morphine hydrochloride (a derivative of Morphine) is reported as an ingredient of Morfina Cloridrato + Atropina Solfato Monico in the following countries:


  • Italy

International Drug Name Search

Sunday 9 October 2011

Anxit




Anxit may be available in the countries listed below.


Ingredient matches for Anxit



Flupentixol

Flupentixol dihydrochloride (a derivative of Flupentixol) is reported as an ingredient of Anxit in the following countries:


  • Bangladesh

International Drug Name Search

Alfacef




Alfacef may be available in the countries listed below.


Ingredient matches for Alfacef



Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Alfacef in the following countries:


  • Vietnam

International Drug Name Search

Saturday 8 October 2011

Ibupain




Ibupain may be available in the countries listed below.


Ingredient matches for Ibupain



Ibuprofen

Ibuprofen is reported as an ingredient of Ibupain in the following countries:


  • South Africa

Paracetamol

Paracetamol is reported as an ingredient of Ibupain in the following countries:


  • South Africa

International Drug Name Search

Wednesday 5 October 2011

dichlorphenamide


Generic Name: dichlorphenamide (dye klor FEN a mide)

Brand Names: Daranide


What is dichlorphenamide?

Dichlorphenamide is a carbonic anhydrase inhibitor. Carbonic anhydrase is a protein in your body. Dichlorphenamide reduces the activity of this protein.


Dichlorphenamide is used to treat glaucoma. By inhibiting the actions of carbonic anhydrase, dichlorphenamide reduces the amount of fluid produced in your eyes and therefore also reduces pressure.


Dichlorphenamide may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about dichlorphenamide?


Call your doctor immediately if you experience a sore throat, fever, unusual bleeding or bruising, tingling or tremors in your hands or feet, pain in your side or groin, or a rash. These symptoms could be early signs of a serious side effect.


Use caution when driving, operating machinery, or performing other hazardous activities. Dichlorphenamide may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Avoid prolonged exposure to sunlight. Dichlorphenamide may increase the sensitivity of your skin to sunlight. Use a sunscreen and wear protective clothing when exposure to the sun is unavoidable.

What should I discuss with my healthcare provider before taking dichlorphenamide?


Tell your doctor if you have ever had an allergic reaction to a sulfa-based drug such as sulfamethoxazole (e.g., Bactrim, Septra, Gantanol). Dichlorphenamide is also a sulfa-based drug, and you may have a similar reaction to it.


Before taking dichlorphenamide, tell your doctor if you



  • are on aspirin therapy,




  • have liver disease,




  • have kidney disease,




  • have heart disease,




  • have lung disease, or




  • have a hormonal disease.



You may not be able to take dichlorphenamide, or you may require a lower dose or special monitoring during treatment if you have any of the conditions listed above.


Dichlorphenamide is in the FDA pregnancy category C. This means that it is not known whether dichlorphenamide will harm an unborn baby. Do not take dichlorphenamide without first talking to your doctor if you are pregnant. It is not known whether dichlorphenamide passes into breast milk. Do not take dichlorphenamide without first talking to your doctor if you are breast-feeding a baby.

How should I take dichlorphenamide?


Take dichlorphenamide exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water. Store dichlorphenamide at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take only your next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of a dichlorphenamide overdose include drowsiness, decreased appetite, nausea, vomiting, dizziness, numbness or tingling, shaking, and ringing in the ears.


What should I avoid while taking dichlorphenamide?


Use caution when driving, operating machinery, or performing other hazardous activities. Dichlorphenamide may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Avoid prolonged exposure to sunlight. Dichlorphenamide may increase the sensitivity of your skin to sunlight. Use a sunscreen and wear protective clothing when exposure to the sun is unavoidable.

Dichlorphenamide side effects


If you experience any of the following serious side effects, seek emergency medical attention:

  • an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);




  • a sore throat or a fever;




  • unusual bleeding or bruising;




  • side or groin pain;




  • tingling or tremors in your hands or feet; or




  • a rash.



Other, less serious side effects may be more likely to occur. Continue to take dichlorphenamide and talk to your doctor if you experience



  • decreased appetite, nausea, vomiting, constipation, diarrhea, or changes in taste;




  • drowsiness, dizziness, fatigue, or weakness;




  • nervousness or tremor;




  • headache or confusion;




  • increased sensitivity of the skin to sunlight;




  • worsening gout;




  • loss of blood sugar control (if you are diabetic);




  • ringing in your ears or hearing problems; or




  • changes in your vision.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect dichlorphenamide?


Before taking this medication, tell your doctor if you are taking any of the following medicines:



  • cyclosporine (Sandimmune). Cyclosporine may have more side effects if it is taken with dichlorphenamide.




  • primidone (Mysoline). Primidone may not be as effective if it is taken with dichlorphenamide, and seizure control may be reduced.




  • diflunisal (Dolobid). Diflunisal may increase both the activity and the side effects of dichlorphenamide.




  • aspirin, salsalate (Disalcid, Salflex, Salsitab, others), choline salicylate (Arthropan), magnesium salicylate (Doan's, Magan, Mobidin), and other aspirin-like products (salicylates). These medicines may also interact with dichlorphenamide, and special monitoring of your therapy may be necessary.




  • lithium (Lithobid, Eskalith, others). Dichlorphenamide may decrease the level of lithium in your blood. Special monitoring or a dosage adjustment may be necessary.



Drugs other than those listed here may also interact with dichlorphenamide. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More dichlorphenamide resources


  • Dichlorphenamide Drug Interactions
  • Dichlorphenamide Support Group
  • 0 Reviews for Dichlorphenamide - Add your own review/rating


Compare dichlorphenamide with other medications


  • Glaucoma
  • Glaucoma/Intraocular Hypertension


Where can I get more information?


  • Your pharmacist has more information about dichlorphenamide written for health professionals that you may read.

What does my medication look like?


Dichlorphenamide is available with a prescription under the brand name Daranide. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.



  • Daranide 50 mg--round, yellow tablets




Tuesday 4 October 2011

CalciDoc




CalciDoc may be available in the countries listed below.


Ingredient matches for CalciDoc



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of CalciDoc in the following countries:


  • Germany

Colecalciferol

Colecalciferol is reported as an ingredient of CalciDoc in the following countries:


  • Germany

International Drug Name Search

Saturday 1 October 2011

Gentamicina Genfar




Gentamicina Genfar may be available in the countries listed below.


Ingredient matches for Gentamicina Genfar



Gentamicin

Gentamicin is reported as an ingredient of Gentamicina Genfar in the following countries:


  • Colombia

  • Ecuador

  • Peru

International Drug Name Search